These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3861482)

  • 1. Immune status of leukemia patients.
    Kaneko Y; Miyakoshi H; Aoyagi Y; Aoki T
    Haematol Blood Transfus; 1985; 29():200-3. PubMed ID: 3861482
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-2 corrects defective NK activity of patients with leukemia.
    Lotzová E; Savary CA
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):169-75. PubMed ID: 3491726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some studies on natural killer cells in man.
    Lotzová E; McCredie KB; Maroun JA; Dicke KA; Freireich EJ
    Transplant Proc; 1979 Jun; 11(2):1390-2. PubMed ID: 314185
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
    Lotzová E; Savary CA; Gutterman JU; Hersh EM
    Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
    [No Abstract]   [Full Text] [Related]  

  • 6. Elicitation of anti-leukemia cytotoxic responses.
    Bach FH; Sondel PM; Zarling JM
    Haematol Blood Transfus; 1979; 23():369-76. PubMed ID: 161756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukemia cell antigens: serologic characterization with xenoantisera.
    Mohanakumar T; Metzgar RS; Miller DS
    J Natl Cancer Inst; 1974 May; 52(5):1435-44. PubMed ID: 4208711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Autoimmune reactivity in patients with leukemia].
    Richter R; Kotlarek-Haus S; Harlozińska A; Brodzka W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):144-51. PubMed ID: 4122957
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.
    Zarling JM; Eskra L; Borden EC; Horoszewicz J; Carter WA
    J Immunol; 1979 Jul; 123(1):63-70. PubMed ID: 286738
    [No Abstract]   [Full Text] [Related]  

  • 10. Killer cells in leukemia.
    Ziegler-Heitbrock HW; Emmerich B; Theml H; Siegert W; Riethmüller G
    Haematol Blood Transfus; 1985; 29():508-10. PubMed ID: 3861488
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification of leukemic cells with T- and O-ALL-specific antisera.
    Rodt H; Netzel B; Thiel E; Jäger G; Huhn D; Haas R; Götze D; Thierfelder S
    Haematol Blood Transfus; 1977; 20():87-96. PubMed ID: 305405
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic markers for human leukemia and lymphoma cells: detection with simian antisera.
    Mohanakumar T; Metzgar RS; Miller DS
    Bibl Haematol; 1975 Oct; (43):24-8. PubMed ID: 1085619
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the mixed leucocyte reaction by target cell death: a study of leukaemic cells.
    Pegrum GD; Evans CA; Middleton VL; Balfour IC
    Clin Exp Immunol; 1972 Feb; 10(2):251-6. PubMed ID: 4505586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukemia associated antigen].
    Berg K; Stavem P
    Tidsskr Nor Laegeforen; 1974 Nov; 94(32):2214-6. PubMed ID: 4531115
    [No Abstract]   [Full Text] [Related]  

  • 15. Heteroantisera against a blast cell antigen.
    Billing R; Terasaki PI; Clark B
    Clin Immunol Immunopathol; 1979 Aug; 13(4):435-43. PubMed ID: 90573
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions.
    Verheyden S; Demanet C
    Leukemia; 2006 Aug; 20(8):1437-8. PubMed ID: 16761016
    [No Abstract]   [Full Text] [Related]  

  • 17. Human leukemia antigens: partial isolation and characterization.
    Metzgar RS; Mohanakumar T; Green RW; Miller DS; Bolognesi DP
    J Natl Cancer Inst; 1974 May; 52(5):1445-53. PubMed ID: 4208712
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactivity of anti-Daudi serum with acute and chronic leukemias.
    Carrel S; Gross N; Mach JP
    Cancer Res; 1979 Dec; 39(12):5171-6. PubMed ID: 315275
    [No Abstract]   [Full Text] [Related]  

  • 19. Decreased natural killer cell activity in children with untreated acute leukemia.
    Nasrallah AG; Miale TD
    Cancer Res; 1983 Nov; 43(11):5580-5. PubMed ID: 6352019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies in the diagnosis of acute leukemia].
    Matolcsy A; Magyarlaki T; Kelényi G
    Orv Hetil; 1985 Jun; 126(24):1459-60, 1463-6. PubMed ID: 3859833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.